SAN DIEGO, CA, March 25, 2010 -- Entest BioMedical Inc. (OTCBB: ENTB) announced today that Chairman & CEO David Koos, along with Lead Inventor Dr. Steven Josephs, provided clarification on the Company's new patent application for use of chemokines in its stem cell / photoceutical therapy for treatment of Chronic Obstructive Pulmonary Disease (COPD) during the Company's weekly blogcast held March 23, 2010.
Entest BioMedical Inc. closed at $1.95 Thursday, trading 19,481 shares.
Entest BioMedical CEO & Lead Inventor Clarify Significance of Chemokine Technology in Potential Efficacy of COPD Stem Cell / Photoceutical Therapy
About Entest BioMedical Inc.
Entest BioMedical Inc. (OTCBB: ENTB) is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), immuno-cancer therapies, testing procedures for diabetes, stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation). ENT-576™ is a proprietary laser device currently under development by Entest. The Company has filed 4 patent applications relating to the treatment of COPD. Entest BioMedical Inc. is a majority owned subsidiary of Bio-Matrix Scientific Group Inc. (OTCBB: BMSN). Recently Entest published in the peer reviewed literature its platform technology, which is available at http://www.translational-medicine.com/content/pdf/1479-5876-7-106.pdf.
For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news
-------------------------------------------
FARMINGDALE, N.Y., March 25, 2010 -- Cemtrex Inc. (OTCBB: CTEI) announced the award of a $1.3 million contract received from the National Administration of Power Plants and Electric Transmissions of Uruguay (UTE) to design, supply, and install complete Continuous Emissions Monitoring Systems (CEMS) for eight stacks with redundant systems for emissions reporting and compliance.
Cemtrex Inc. closed at $0.20 Thursday, trading 7,000 shares.
Cemtrex Secures Emission Monitoring System Contract in Uruguay
About Cemtrex Inc.
Cemtrex Inc. is a worldwide market leader in manufacturing and selling the most advanced instruments for emission monitoring of particulate, opacity, mercury, sulfur dioxide, nitrogen oxides, etc. and filtration products for the industry. Cemtrex also markets Green DCV, an innovative energy efficiency solution for high-quality green building applications, through optimizing HVAC control systems. Cemtrex provides technologies and services for abatement of greenhouse gases and assists customers in developing carbon credit projects. The Company's products are sold to power plants, refineries, chemical plants, cement plants and other industries, including federal and state governmental agencies.
For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news
-------------------------------------------
StockProfiler.US Announcement!
Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://stockprofiler.us/index.php?action=main.register
Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS
View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS
-------------------------------------------
About StockProfiler.US:
StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.
Call us at (603) 424-4420 or email info@stockprofiler.us
-------------------------------------------
Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.
This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.
Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
To view full disclaimers and terms of use, go to http://stockprofiler.us/?action=main.disclaimer
-------------------------------------------
Keywords: small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news, small cap stock profile
Posts
No comments:
Post a Comment